• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Do We Have Enough Evidence to Propose a Preferred Total Neoadjuvant Therapy Sequence for Patients With Locally Advanced Rectal Cancer?

作者信息

Siegel Robert

机构信息

Colorectal Cancer Center, Department of General, Visceral and Cancer Surgery, Helios Klinikum Berlin-Buch, Berlin, Germany.

Faculty of Health, Witten/Herdecke University, Witten, Germany.

出版信息

JAMA Oncol. 2022 May 1;8(5):781-782. doi: 10.1001/jamaoncol.2022.0232.

DOI:10.1001/jamaoncol.2022.0232
PMID:35357411
Abstract
摘要

相似文献

1
Do We Have Enough Evidence to Propose a Preferred Total Neoadjuvant Therapy Sequence for Patients With Locally Advanced Rectal Cancer?
JAMA Oncol. 2022 May 1;8(5):781-782. doi: 10.1001/jamaoncol.2022.0232.
2
Do We Have Enough Evidence to Propose a Preferred Total Neoadjuvant Therapy Sequence for Patients With Locally Advanced Rectal Cancer?-Reply.我们是否有足够的证据为局部晚期直肠癌患者推荐一种首选的全新辅助治疗方案？-回复
JAMA Oncol. 2022 May 1;8(5):782-783. doi: 10.1001/jamaoncol.2022.0235.
3
[Intensification and Personalization of Neoadjuvant Therapy for Locally Advanced Rectal Cancer].
Praxis (Bern 1994). 2023 Sep;112(11):537.
4
[Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].[局部晚期高危直肠癌患者新辅助综合治疗的疗效与安全性分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Apr 25;22(4):349-356. doi: 10.3760/cma.j.issn.1671-0274.2019.04.007.
5
[Ⅳ. Prospects for Total Neoadjuvant Therapy for Patients with MSS Locally Advanced Rectal Cancer].[Ⅳ. 错配修复缺陷（dMMR）或微卫星高度不稳定（MSI-H）局部晚期直肠癌患者新辅助治疗的前景] 你提供的原文中“MSS”可能有误，根据常见医学内容推测这里应该是“dMMR/MSI-H”，我按照修正后的内容进行了翻译，若实际情况并非如此，请你指出以便我更准确翻译。
Gan To Kagaku Ryoho. 2023 Nov;50(11):1182-1184.
6
Tailored total neoadjuvant therapy for locally advanced rectal cancer: One size may not fit for all!个体化新辅助治疗局部进展期直肠癌：一种方法并不适合所有人！
Colorectal Dis. 2021 Jul;23(7):1662-1669. doi: 10.1111/codi.15669. Epub 2021 Apr 22.
7
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Induction or Consolidation Chemotherapy?局部晚期直肠癌的全新辅助治疗：诱导化疗还是巩固化疗？
J Clin Oncol. 2022 Aug 10;40(23):2515-2519. doi: 10.1200/JCO.22.00506. Epub 2022 Jun 20.
8
Oncologic and survival outcomes in elderly patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy and total mesorectal excision.接受新辅助放化疗及全直肠系膜切除术的老年局部晚期直肠癌患者的肿瘤学及生存结局
Jpn J Clin Oncol. 2021 Aug 30;51(9):1391-1399. doi: 10.1093/jjco/hyab095.
9
Chemoradiotherapy in Locally Advanced Rectal Cancer: Surgeon Perspective.局部晚期直肠癌的放化疗：外科医生视角
J Clin Oncol. 2022 Dec 1;40(34):4029. doi: 10.1200/JCO.22.00934. Epub 2022 Aug 5.
10
mFOLFOXIRI versus mFOLFOX6 as neoadjuvant chemotherapy in locally advanced rectal cancer: A Propensity Score Matching Analysis.mFOLFOXIRI与mFOLFOX6作为局部晚期直肠癌新辅助化疗的倾向评分匹配分析
Clin Colorectal Cancer. 2022 Mar;21(1):e12-e20. doi: 10.1016/j.clcc.2021.11.009. Epub 2021 Nov 28.